STAMBP and systemic sclerosis: In terms of its relationship with SSc, αMSH has been reported to suppress skin fibrosis in the bleomycin (BLM)-induced skin fibrosis model, which is the most widely used SSc animal model [24], and deficient MC1R signaling exacerbates BLM-induced skin fibrosis in mice [25].